医院@家:改善多病共存患者出院管理并降低再住院风险的随机临床试验方案
该方案描述一项务实、随机、开放标签、单中心优效性试验,随访30天,纳入急性内科病房计划出院回家且30天再住院风险估计≥20%的成年患者。干预组接受跨学科团队个体化协调出院管理(含出院前、过渡期和出院后多模式干预),对照组接受常规出院流程,主要终点为30天再住院率。
要点
- 针对再住院高风险(≥20%)的多病共存出院患者设计个体化过渡期干预。
- 干预涵盖出院前、过渡期和出院后多模式协调管理,由跨学科团队实施。
- 主要终点为30天再住院率,采用随机开放标签优效性设计验证效果。
核心结论
- 该试验旨在评估定义明确的多组分出院干预能否降低高风险患者非计划再住院率。
研究设计与样本
- 务实、随机、开放标签、单中心优效性试验,随访30天。
- 纳入急性内科病房住院、计划出院回家且30天再住院风险估计≥20%的成年患者。
- 干预组接受跨学科团队个体化协调出院管理,对照组接受常规出院流程。
关键数值与推荐
- 纳入标准:计划出院回家且30天再住院风险估计为20%或以上的成年患者。
- 干预组接受个体化出院前、过渡期和出院后多模式干预。
- 主要终点为30天再住院率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hospital rehospitalizations within 30 days represent a burden for patients and the healthcare system. Improving the care during the hospital discharge period could decrease the risk of avoidable rehospitalizations. AIM: To describe the methods of our trial aiming to define the efficacy of a tailored transition program in patients with high risk for rehospitalization compared to the usual discharge procedure with the endpoint of 30 day rehospitalization rate. METHODS: Pragmatic, randomized, open-label, single-center superiority trial with a follow-up of 30 days. Included are adult patients hospitalized in an acute internal medicine department who are planned to be discharged home with a high estimated risk (20% or more) of 30-day rehospitalization. Patients in the intervention group will receive individualized and coordinated discharge management by an interdisciplinary team, compared to usual care in the control group. The multimodal intervention includes individualized pre-discharge, bridging, and post-discharge intervention components. ETHICS AND DISSEMINATION: Before enrolling the first patient, the trial was prospectively registered at the ISRCTN registry (registration date April 4th 2023) under the number ISRCTN11162162 and was approved by the ethical committee (Ethikkommission Nordwest- und Zentralschweiz (EKNZ), ID 2022-01040). CONCLUSION: This trial aims to assess the efficacy of a well-defined multicomponent discharge intervention to reduce unplanned rehospitalization rates in high-risk patients.
引用
- Brennecke F, Neurauter S, Werner M, et al. Hospital@Home: improving discharge management and reducing the risk of rehospitalizations in multimorbid Patients - Protocol for a randomized clinical trial. Trials. 2026. PMID: 41862957. doi:10.1186/s13063-026-09614-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。